Merck (MRK) is a publicly traded Healthcare sector company. As of July 15, 2026, MRK trades at $120.80 with a market cap of $306.33B and a P/E ratio of 33.80. MRK moved -2.62% today. Year to date, MRK is +14.74%; over the trailing twelve months it is +44.35%. Its 52-week range spans $73.31 to $130.29. Analyst consensus is buy with an average price target of $140.31. Rallies surfaces MRK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
18 analysts cover MRK: 0 strong buy, 13 buy, 5 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $140.31.
| Metric | Value |
|---|---|
| Price | $120.80 |
| Market Cap | $306.33B |
| P/E Ratio | 33.80 |
| EPS | $3.57 |
| Dividend Yield | 0.85% |
| 52-Week High | $130.29 |
| 52-Week Low | $73.31 |
| Volume | 6.14M |
| Avg Volume | 0 |
| Revenue (TTM) | $65.77B |
| Net Income | $8.93B |
| Gross Margin | 73.91% |
18 analysts cover MRK: 0 strong buy, 13 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $140.31.